Education
About Us
Working with TipRanks
Follow Us
Alector Inc (ALEC)
NASDAQ:ALEC
ALEC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.55 - $7.45
Previous CloseN/A
Volume194.31K
Average Volume (3M)590.52K
Market Cap
$162.50M
Enterprise Value$31.88M
Total Cash (Recent Filing)$74.56M
Total Debt (Recent Filing)$38.92M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
May 01, 2025EPS Estimate
-0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding99,085,890
10 Day Avg. Volume759,117
30 Day Avg. Volume590,523
Standard Deviation0.18
R-Squared0.03
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.62
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.34
Enterprise Value/Ebitda-0.18
Forecast
1Y Price Target
$4.30Price Target Upside162.20% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Alector News
PremiumCompany Announcements
Alector’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Alector’s 2024 Financial Results and Clinical Advancements
---
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentResults from the open-label Phase II INFRONT-2 study showed a 48% slowing of disease relative to an external matched control cohort.
Financial StabilityThe company reported cash through 2026, indicating strong financial stability.
Bears Say
CompetitionCrowding and competition are expected to be an issue in Alector's efforts.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ALEC FAQ
What was Alector Inc’s price range in the past 12 months?
Alector Inc lowest stock price was $1.55 and its highest was $7.45 in the past 12 months.
What is Alector Inc’s market cap?
Alector Inc’s market cap is $162.50M.
When is Alector Inc’s upcoming earnings report date?
Alector Inc’s upcoming earnings report date is May 01, 2025 which is in 58 days.
How were Alector Inc’s earnings last quarter?
Alector Inc released its earnings results on Feb 26, 2025. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.623 by $0.603.
Is Alector Inc overvalued?
According to Wall Street analysts Alector Inc’s price is currently Undervalued.
Does Alector Inc pay dividends?
Alector Inc does not currently pay dividends.
What is Alector Inc’s EPS estimate?
Alector Inc’s EPS estimate is -0.48.
How many shares outstanding does Alector Inc have?
Alector Inc has 99,085,890 shares outstanding.
What happened to Alector Inc’s price movement after its last earnings report?
Alector Inc reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.623. Following the earnings report the stock price went down -3.488%.
Which hedge fund is a major shareholder of Alector Inc?
Currently, no hedge funds are holding shares in ALEC
---
Alector Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.30 (162.20% Upside)
$4.30 (162.20% Upside)
Blogger Sentiment
Neutral
ALEC Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 8.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $276.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.53%
12-Months-Change
Fundamentals
Return on Equity
-91.24%
Trailing 12-Months
Asset Growth
-24.69%
Trailing 12-Months
Company Description
Alector Inc
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
---
ALEC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in clinical trials, increased collaboration revenue for the quarter, and a strong cash position. However, minimal year-over-year revenue growth and sustained high R&D expenses present challenges.Read More>---
ALEC Stock 12 Month Forecast
Average Price Target
$4.30
▲(162.20% Upside)
Technical Analysis
Best Analysts Covering ALEC
1 Year
1 Year Success Rate
4/14 ratings generated profit
1 Year Average Return
-17.79%
reiterated a buy rating 6 days ago
Copying Yaron Werber's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -17.79% per trade.
---